There are two words we hear more and more in the era of modern marketing communications: data and storytelling. At face value, they seem like very separate entities.
Ahead of the eyeforpharma Awards shortlist announcement this week, we spoke to judge and commercial insights executive Peter Barschdorff about how data and insights are changing pharma
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS